Cytodyn Inc. (CYDY) — 10-K Filings
All 10-K filings from Cytodyn Inc.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
CytoDyn Remains Revenue-Less, Focuses on Leronlimab Development
— Jul 25, 2025 Risk: high
CytoDyn Inc. reported no revenue for the fiscal year ended May 31, 2025, consistent with its pre-commercial stage. The company's net loss was not explicitly sta -
CytoDyn Inc. Files 2024 Annual Report
— Aug 15, 2024 Risk: medium
CytoDyn Inc. filed its 10-K for the fiscal year ending May 31, 2024. The company, previously known as Rexray Corp, is incorporated in Delaware and operates in t
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX